Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications

Journal of the American College of Cardiology

Volumn 62, Issue 8, 2013, Pages 732-739

  Martin, Seth S ^a   Blaha, Michael J ^a   Elshazly, Mohamed B ^a   Brinton, Eliot A ^b   Toth, Peter P ^c,d   McEvoy, John W ^a   Joshi, Parag H ^a   Kulkarni, Krishnaji R ^e   Mize, Patrick D ^e   Kwiterovich, Peter O ^a   Defilippis, Andrew P ^a,f   Blumenthal, Roger S ^a   Jones, Steven R ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b Utah Foundation for Biomedical Research   (United States)

^c CGH Medical Center   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

^e Atherotech Diagnostics Inc   (United States)

^f University of Louisville School of Medicine   (United States)

Author keywords

Friedewald equation; low density lipoprotein cholesterol; very low density lipoprotein cholesterol

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACCURACY; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLASSIFICATION; DENSITY GRADIENT CENTRIFUGATION; FEMALE; FRIEDWALD EQUATION; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; TREATMENT PLANNING; TRIACYLGLYCEROL BLOOD LEVEL;

FRIEDEWALD EQUATION; HDL-C; HIGH-DENSITY LIPOPROTEIN CHOLESTEROL; LDL-C; LOW-DENSITY LIPOPROTEIN CHOLESTEROL; NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY; NHANES; VAP; VERTICAL AUTO PROFILE; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; VLDL-C;

ADULT; AGED; APOLIPOPROTEINS B; BLOOD CHEMICAL ANALYSIS; CENTRIFUGATION, DENSITY GRADIENT; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; TRIGLYCERIDES;

EID: 84880620607     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.01.079     Document Type: Article

References (18)

1. Third Report of the NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Circulation 106 2002 3143 3421
2. S.M. Grundy, J.I. Cleeman, and C.N. Merz Implications of recent clinical trials for the NCEP ATP III guidelines J Am Coll Cardiol 44 2004 720 732
3. S.C. Smith Jr., E.J. Benjamin, and R.O. Bonow AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update J Am Coll Cardiol 58 2011 2432 2446
4. Z. Reiner, A.L. Catapano, and G. De Backer ESC/EAS guidelines for the management of dyslipidaemias Eur Heart J 32 2011 1769 1818
5. J. Genest, R. McPherson, and J. Frohlich 2009 Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult Can J Cardiol 25 2009 567 579
6. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
7. M. Miller, N.J. Stone, and C. Ballantyne Triglycerides and cardiovascular disease: a scientific statement from the AHA Circulation 123 2011 2292 2333
8. L. Sibal, R.D. Neely, A. Jones, and P.D. Home Friedewald equation underestimates LDL-C at low concentrations in young people with and without type 1 diabetes Diabet Med 27 2010 37 45
9. H. Scharnagl, M. Nauck, H. Wieland, and W. Marz The Friedewald formula underestimates LDL-C at low concentrations Clin Chem Lab Med 39 2001 426 431
10. K.R. Jun, H.I. Park, S. Chun, H. Park, and W.K. Min Effects of total cholesterol and triglyceride on the percentage difference between the LDL-C concentration measured directly and calculated using the Friedewald formula Clin Chem Lab Med 46 2008 371 375
11. C.C. Lindsey, M.R. Graham, T.P. Johnston, C.G. Kiroff, and A. Freshley A clinical comparison of calculated versus direct measurement of low-density lipoprotein cholesterol level Pharmacotherapy 24 2004 167 172
12. K.R. Kulkarni Cholesterol profile measurement by VAP method Clin Lab Med 26 2006 787 802
13. Working Group on Lipoprotein Measurement NCEP recommendations for measurement of low-density lipoprotein cholesterol: executive summary Clin Chem 41 1995 1414 1426
14. E.V. Kuklina, P.W. Yoon, and N.L. Keenan Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999-2006 JAMA 302 2009 2104 2110
15. D.M. DeLong, E.R. DeLong, P.D. Wood, K. Lippel, and B.M. Rifkind A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol The Lipid Research Clinics Prevalence Study JAMA 256 1986 2372 2377
16. J.J. Kastelein, W.A. van der Steeg, and I. Holme Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment Circulation 117 2008 3002 3009
17. V. Ramjee, L.S. Sperling, and T.A. Jacobson NonHDL-C versus apoB in cardiovascular risk stratification: do the math J Am Coll Cardiol 58 2011 457 463
18. C. Li, L.S. Balluz, and C.A. Okoro Surveillance of certain health behaviors and conditions among states and selected local areas MMWR Surveill Summ 60 2011 1 250